Literature DB >> 15318663

Better preadmission assessment improves learning disability care.

Lyn Hannon1.   

Abstract

AIM: This qualitative study explores the experience of hospital admission from the perspective of four different stakeholders: people with a learning disability, their family/carers, hospital staff, and community learning disability nurses. It introduces and evaluates a new preadmission assessment, identifies key factors that influence the process of health care, and compares the results of this study with the current evidence base.
METHOD: Process evaluation with multiple stakeholder analysis using semi-structured interviews for data collection. A focus group was used in preparation for the study.
FINDINGS: Stakeholders were generally positive about their experiences, and the preadmission assessment was well received.
CONCLUSION: Preadmission assessment of people with learning disabilities can be helpful to all concerned as it helps the different stakeholders to understand each other and their needs.

Entities:  

Mesh:

Year:  2004        PMID: 15318663

Source DB:  PubMed          Journal:  Nurs Times        ISSN: 0954-7762


  3 in total

1.  Nurses' experiences of caring for patients with intellectual developmental disorders: a systematic review using a meta-ethnographic approach.

Authors:  Marie Appelgren; Christel Bahtsevani; Karin Persson; Gunilla Borglin
Journal:  BMC Nurs       Date:  2018-12-03

Review 2.  A metasynthesis of patient-provider communication in hospital for patients with severe communication disabilities: informing new translational research.

Authors:  Bronwyn Hemsley; Susan Balandin
Journal:  Augment Altern Commun       Date:  2014-09-17       Impact factor: 2.214

3.  Specialist psychiatric health care utilization among older people with intellectual disability - predictors and comparisons with the general population: a national register study.

Authors:  G Ahlström; A Axmon; M Sandberg; J Hultqvist
Journal:  BMC Psychiatry       Date:  2020-02-17       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.